Form 4: Insight Holdings Group Reports Hinge Health Stock Transactions

Insight Holdings Group, LLC and affiliated entities reported transactions involving Hinge Health, Inc. Class A and Class B common stock on June 16, 2026.

Summary

• Insight Holdings Group, LLC and several affiliated entities (Insight Venture Associates X, Ltd., Insight Venture Associates X, L.P., Insight Venture Partners X, L.P., Insight Venture Partners (Cayman) X, L.P., Insight Venture Partners (Delaware) X, L.P., and Insight Venture Partners X (Co-Investors), L.P.) have filed a Form 4 detailing transactions in Hinge Health, Inc. (HNGE) stock.
• The transactions occurred on June 16, 2026.
• These transactions involved the conversion of Class B Common Stock into Class A Common Stock and the subsequent sale of Class A Common Stock.
• A total of 65,581 shares of Class A Common Stock were acquired through conversion (32,751 + 779 + 26,856 + 5,195).
• Following these acquisitions, 65,581 shares of Class A Common Stock were disposed of (sold) at a weighted average price of $70.3596 per share, with prices ranging from $70.01 to $70.62.
• The reporting persons are deemed to be 10% owners and directors of Hinge Health, Inc.
• The transactions were made pursuant to a Rule 10b5-1 trading plan adopted on August 20, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine transactions by a major investor under a pre-established plan, rather than indicating new strategic developments or significant shifts in company performance.

Positives

• The reporting persons executed transactions under a pre-established Rule 10b5-1 plan, indicating a structured and potentially pre-determined approach to trading.
• The sale of Class A Common Stock occurred at a weighted average price of $70.3596, suggesting a favorable exit price for a portion of their holdings.

Negatives

• The filing indicates a disposition (sale) of a significant number of Class A Common Stock shares (65,581 shares).
• The reporting entities are selling shares, which could be interpreted as a reduction in their stake or confidence, although this is common for investment firms.

Risks

• The sale of a substantial number of shares could signal a potential decrease in the reporting entities' long-term outlook for the stock, although this is typical for venture capital firms realizing gains.
• The reliance on a Rule 10b5-1 plan, while providing an affirmative defense against insider trading allegations, still involves the disposal of securities, which can impact market perception.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Hinge Health, Inc. It solely reports past transactions by Insight Holdings Group and its affiliates.

Management Comments

• The reporting persons disclaim beneficial ownership of shares held by other Insight Entities, except to the extent of their pecuniary interest.
• The reporting persons undertake to provide full information regarding the number of shares sold at each separate price within the reported range upon request.

Industry Context

StockSavvy.ai notes that Form 4 filings from significant investors like Insight Holdings Group are common for venture capital and private equity firms as they manage their portfolio investments, often involving conversions and sales of stock upon reaching certain milestones or liquidity events.

Stakeholder Impact

• Shareholders: The sale of shares by a significant owner could be perceived negatively by some, but it is a standard practice for investment firms to realize gains. The weighted average sale price provides a benchmark for recent trading activity.
• Creditors: No direct impact is indicated.
• Employees: No direct impact is indicated.
• Suppliers/Customers: No direct impact is indicated.

Next Steps

• The reporting persons may continue to execute trades under the Rule 10b5-1 plan.
• The company, Hinge Health, Inc., may provide further updates on its performance or strategy in subsequent filings.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Hinge Health, HNGE, Insight Holdings Group, Class A Common Stock, Class B Common Stock, Rule 10b5-1, Stock Transaction, Beneficial Ownership